Janus Kinase Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
RIGL | F | Rigel Pharmaceuticals, Inc. | -5.41 | |
GLPG | F | Galapagos NV | -1.06 |
Related Industries: Biotechnology
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
SBIO | D | ALPS Medical Breakthroughs ETF | 1.31 | |
BIS | A | ProShares UltraShort Nasdaq Biotechnology | 0.22 | |
IBB | D | iShares Nasdaq Biotechnology Index Fund | 0.18 | |
IBBQ | D | Invesco Nasdaq Biotechnology ETF | 0.07 | |
BTEC | C | Principal Healthcare Innovators Index ETF | 0.07 |
Compare ETFs
Date | Stock | Title |
---|---|---|
Apr 12 | RIGL | Silence Therapeutics (SLN) Surges 5.7%: Is This an Indication of Further Gains? |
Related Industries:
Biotechnology
- Janus Kinase
Janus kinase (JAK) is a family of intracellular, nonreceptor tyrosine kinases that transduce cytokine-mediated signals via the JAK-STAT pathway. They were initially named "just another kinase" 1 and 2 (since they were just two of a large number of discoveries in a PCR-based screen of kinases), but were ultimately published as "Janus kinase". The name is taken from the two-faced Roman god of beginnings, endings and duality, Janus, because the JAKs possess two near-identical phosphate-transferring domains. One domain exhibits the kinase activity, while the other negatively regulates the kinase activity of the first.
Recent Comments
- TraderMike on IZM
- TraderMike on Today's Outage
- Crunching_The_Market on Today's Outage
- TraderMike on Market Recap for Friday, March 8, 2024
- Don_Marat on Market Recap for Friday, March 8, 2024
From the Blog
Featured Articles